Indoco Remedies Ltd., a renowned player in the global pharmaceutical industry, has announced receiving tentative approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Canagliflozin Tablets in 100 mg and 300 mg strengths. These tablets are the generic equivalent of the Reference Listed Drug, Invokana Tablets, […]
Global pharmaceutical leader, Lupin Limited, announced its significant achievement of receiving tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Canagliflozin Tablets, both 100 mg and 300 mg. This approval allows Lupin to market a generic equivalent of Invokana Tablets, manufactured by Janssen Pharmaceuticals, […]
